Lymphovascular (LVI) and Perineural Invasion (PNI) in Colorectal Carcinoma and Their Association with Tumor Stages: A Retrospective Study on 250 Cases in Bangabandhu Sheikh Mujib Medical University

Article Information

Mohammad Zillur Rahman1, Mohammad Shukur Ali2, Syeda Rumman Aktar Siddiqui3

1Professor and Chairman, Department of Pathology, Bangabandhu Sheikh Mujib medical university (BSMMU), Shahbag, Dhaka, Bangladesh.

2Professor, Department of English, University of Development Alternative (UODA), Dhaka, Bangladesh.

3Syeda Rumman Aktar Siddiqui, MBBS, M Phil (Biochemistry), Associate Professor, Department of Biochemistry Chittagong Medical College, Chattogram, Bangladesh.

*Corresponding author: Mohammad Zillur Rahman, Professor and Chairman, Department of Pathology, Bangabandhu Sheikh Mujib medical university (BSMMU), Shahbag, Dhaka, Bangladesh

Received: 29 July 2024; Accepted: 31 July 2024; Published: 19 August 2024

Citation: Mohammad Zillur Rahman, Mohammad Shukur Ali, Syeda Rumman Aktar Siddiqui. Lymphovascular (LVI) and Perineural Invasion (PNI) in Colorectal Carcinoma and Their Association with Tumor Stages: A Retrospective Study on 250 Cases in Bangabandhu Sheikh Mujib Medical University. Fortune Journal of Health Sciences. 7 (2024): 453-458

View / Download Pdf Share at Facebook

Abstract

Introduction: Colorectal cancer (CRC) is the most prevalent type of cancer and ranks as the fifth leading cause of cancer-related death. Despite advancements in technology and treatment, recurrence and metastases continue to be significant issues, leading to decreased patients’ survival. Lymphovascular invasion (LVI) involves small lymphatic or blood (typically venous) vessels within the tumor, while perineural invasion (PNI) is the tumor invasion of the perineural sheath or epineurium. LVI and PNI may be the significant indicators for CRC prognosis and progression. This paper aimed to determine the association between lymphovascular invasion (LVI) and perineural invasion (PNI) with the tumor stages of colorectal carcinoma.

Methods: This retrospective cross-sectional descriptive type of study was conducted at the Department of Pathology in Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh during January, 2024 to June, 2024. A consecutive sampling technique was used and a series of 250 excised cases of colorectal carcinoma irrespective of age and sex were retrospectively enrolled in this study. The data were analyzed using Statistical Package for Social Sciences (SPSS) software, version-23.0.

Results: A series of 250 excised cases of colorectal carcinoma irrespective of age and sex were enrolled in this study. The mean age of the patients was 47.89±15.71 years. Most cases (143, 57.20%) were males. Ascending colon was the most frequent (74, 29.6%) site of the growth of colorectal carcinoma.The most frequent histologic type of colorectal carcinoma was found to be adenocarcinoma NOS 203(81.2%). The most frequent histological grade was marked as low grade (207, 82.8%). Among the stages of pT, the most frequent stage was identified as pT3 (153, 61.2%) and among pN, the most frequent stage was found to be pN0 (140, 56%). The lymphovascular invasion (LVI) and perineural invasion (PNI) were significantly associated with the tumour stages of colorectal carcinoma (p= <0.001).

Conclusion: In conclusion, this study provides valuable insights into the clinicopathological characteristics of CRC in Bangladeshi patients. Lymphovascular invasion (LVI) and perineural invasion (PNI) were significantly associated with tumor stages of colorectal carcinoma which indicates LVI and PNI are the significant prognostic indicators of the CRC disease progression and prognosis

Keywords

Lymphovascular, Perineural, Invasion, Association, Tumor, Stages

Lymphovascular articles, Perineural articles, Invasion articles, Association articles, Tumor articles, Stages articles

Article Details

1. Introduction

Colorectal cancer (CRC) is the most prevalent type of cancer and ranks as the fifth leading cause of cancer-related death [1]. Despite advancements in technology and treatment, recurrence and metastases continue to be significant issues, leading to decreased patients’ survival [2]. The disease's extent, critical for determining treatment options and prognosis, is categorized using the American Joint Committee on Cancer (AJCC) staging system. This TNM classification considers various histopathological features: tumor invasion depth (T), lymph node metastasis (N), and the presence of metastatic disease (M) [3]. However, the TNM classification alone is insufficient for predicting CRC prognosis, as patients with the same TNM stage may have different survival times and recurrence rates [4.]. Several risk factors for poor prognosis have been identified, including the stage T4 tumor, perforation, obstruction, high-grade tumor, lymphovascular invasion (LVI) or perineural invasion (PNI), positive resection margin, and/or removal of fewer than 12 lymph nodes [5,6]. Various international guidelines, such as those from the American Society of Clinical Oncology (ASCO), the National Comprehensive Cancer Network, and the European Society of Medical Oncology, recommend adjuvant chemotherapy for stage II patients with these risk factors [7]. However, conclusive evidence supporting the efficacy of adjuvant chemotherapy in this patient group is lacking, and conflicting results have been reported regarding its benefits even in high-risk patients [8,9].  Lymphovascular invasion (LVI) involves small lymphatic or blood (typically venous) vessels within the tumor, while PNI is defined as the tumor invasion of the perineural sheath or epineurium. [10, 11]. Histopathological identification of lymphovascular invasion (LVI) has long been considered a potential prognostic indicator due to its association with increased lymphatic metastasis .Similarly, PNI has been linked to more aggressive tumor phenotypes and poor prognoses in various cancers [12-14]. However, there are very few studies and limited data on lymphovascular (LVI) and perineural invasion (PNI) in colorectal carcinoma and their association with tumor stages in Bangladesh context. This study aimed to determine the lymphovascular (LVI) and perineural invasion (PNI) in colorectal carcinoma and their association with tumor stages of the excised cases attended in Bangabandhu Sheikh Mujin Medical University (BSMMU), Dhaka, Bangladesh.

Methods

This retrospective cross-sectional descriptive type of study was conducted at the Department of Pathology in Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh during January, 2024 to June, 2024. A consecutive sampling technique was used and a series of 250 excised cases of colorectal carcinoma irrespective of age and sex were retrospectively enrolled in this study. The tumors were classified following World Health Organization (WHO) Classification of tumours of the Digestive System [15] and grading of tumor was classified by using Canadian Cancer Society (CCS) specified two-tiered grading system [16]. Staging was performed following TNM Classification of Colorectal Carcinoma of American Cancer Society, 2020[17].The data were collected using Excel data sheet from the registry of Pathology Department of Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh. The collected data were methodically ordered, edited and coded for computer entry. The data were analyzed using Statistical Package for Social Sciences (SPSS) software, version-23.0. Descriptive statistical analysis were performed and the results were presented in tables and charts. Chi-square tests were performed to assess the association between lymphovascular and perineural invasion with the tumor stages of colorectal carcinoma, where P< 0.05 considered as the level of significance with 95% CI. During the assessment of association between LVI and PNI with the tumor stages, the undetermined cases were excluded.

Table 1: Demographic characteristics of the study patients (N=250)

Demographic characteristics

Frequency

Percent

N

Age(years)

<20

2

0.8

21-40

76

30.4

41-60

116

46.4

61-80

54

21.6

>81

2

0.8

Total

250

100

Mean age (years)

47.89±15.71

Median

43

Mode

44

Sex

Male

143

57.2

Female

107

42.8

Total

Table 1: shows the Demographic characteristics of the study patients. The most frequent age group was 41-60years which includes 116(46.4%) patients followed by 21-40 years, 76(30.4%), 61-80years, 54(21.6%) both <20 and>81 years includes the same 2(0.8%) patients. The mean age was (47.89±15.71) years, with the age of median 43byears and mode of 44 years. The most cases 143(57.20%) were males and 107(42.805) were females.

Table 2: Site distribution of colorectal growth with the study patients (N=250)

Sites

Frequency

percent

N

Anal canal

2

0.8

Mesorecturm

2

0.8

Rectum

23

9.2

Recto sigmoid

21

8.4

Sigmoid

64

25.6

Mesocolon

2

0.8

Descending colon

5

2

Transverse colon

5

2

Ascending colon

74

29.6

Ileocaecal

2

0.8

Colon not specified

50

20

Total

250

100

 

Table 2 shows the site distribution of the growth of colorectal carcinoma with the study patients. The most frequent site of the growth of the colorectal carcinoma was observed at ascending colon in 74(29.6%) patients followed sigmoid colon in 64(25.6%), colon not specified in 50(20%), rectum region in 23(9.2%), recto sigmoid in 21(8.4%), descending colon in 5(2.00%) ,transverse colon in 5(2.00%),Ileocaecal region in 2(0.8%), mesorectum  in 2(0.8%) and anal canal in only 2(0.8%).

Table 3: Distribution of histologic type of colorectal carcinoma (N=250).

Histologic type of

Frequency

Percent

colorectal carcinoma

N

Adenocarcinoma NOS

203

81.2

Mucinous Adenocarcinoma

45

18

Papillary Adenocarcinoma

2

0.8

Total

250

100

Table 3 shows the distribution of histologic type of colorectal carcinoma with the study patients. The most frequent histologic type of colorectal carcinoma was adenocarcinoma NOS found in 203(81.2%) patients followed mucinous adenocarcinoma 45(18%), papillary adenocarcinoma in only 2(0.8%).

Table 4: Grade distribution of observed colorectal carcinoma (N=250).

Histologic Grade of

Frequency

Colorectal carcinoma

N

Percent

Low grade

207

82.8

High grade

43

17.2

Total

250

100

Table 4 shows the grade distribution of observed colorectal carcinoma. The most frequent grade of colorectal carcinoma was observed low grade in 207(82.8%) and 43(17.2%) cases were high grade.

Table 5:  Lymphovascular and perineural invasion counted in total colorectal carcinoma cases (N=250).

Lymphovascular invasion

Present

Absent

Undetermined

Total

83

50

117

250

Perineural invasion

83

50

117

250

Table 5 shows the lymphovascular and perineural invasion counting in total colorectal carcinoma cases.  Among 250 colorectal carcinoma cases, lymphovascular and perineural invasion were counted Present in 83(33.2%) patients absent in 50(20%) patients and 117(46.8%) patients were remained undetermined.

Table 6: Association between lymphovascular invasion and stages of colorectal carcinoma (n=133).

 Stages(T)

Lymphovascular  Invasion of colorectal carcinoma

Total

P-value

Present

Absent

N(%)

N(%)

pT0

1(1.20)

0(0%)

1

pT1

10(12.04)

1(2)

11

pT2

49(59.03)

17(34)

66

pT3

23(27.71)

32(64)

55

<0.001

pT4

0(0)

0(0)

0

Total

83(100)

50(100)

133

Stages (N)

pNx

3

1

4

pN0

80

49

129

pN1

0

0

0

<0.001

pN1a

0

0

0

pN1b

0

0

0

pN1c

0

0

0

pN2

0

0

0

pNa

0

0

0

pN2b

0

0

0

Total

83

50

133

 

Table-6 illustrates the association between lymphovascular invasion and stages of colorectal carcinoma. Among the patients, 83 (32.2%) exhibited the presence of lymphovascular invasion. Of these, 1 (1.20%) patient was classified as stage pT0, followed by 10 (12.04%) at pT1, 49 (59.03%) at pT2, and 23 (27.71%) at pT3. Conversely, 50 (20%) patients had lymphovascular invasion absent, with 1 (2%) patient at pT1, 17 (34%) at pT2, and 32 (64%) at pT3. This distribution yielded a statistically significant association (p < 0.001) between lymphovascular invasion and tumor stages. Furthermore, regarding lymph node stages (pN), 3 (3.61%) patients with lymphovascular invasion had pNx, while 80 (96.38%) were classified as pN0. Among those without lymphovascular invasion, 1 (1.20%) patient was at pNx, and 49 (98%) were at pN0. This distribution also demonstrated a statistically significant association (p < 0.001) between lymphovascular invasion and lymph node stages. Overall, the text emphasizes a strong association between lymphovascular invasion and both tumor and lymph node stages in colorectal carcinoma, indicating its potential value as a significant prognostic indicator in the disease's progression.

Table 7: Association between perineural invasion and stages of colorectal carcinoma (n=250).

Stages(T)

Perineural Invasion  of  colorectal carcinoma

Total

P-value

Present

Absent

N(%)

N(%)

pT0

0

0

0

pT1

10

1

11

pT2

49

18

67

pT3

24

30

54

<0.001

pT4

0

0

0

Total

83

50

133

Stages (N)

pNx

3

2

5

pN0

80

48

128

pN1

0

0

0

     <0.001

pN1a

0

0

0

pN1b

0

0

0

pN1c

0

0

0

pN2

0

0

0

pNa

0

0

0

pN2b

0

0

0

Total

83

50

133

Table-7 shows the presence or absence of perineural invasion (PNI) in colorectal carcinoma across different tumor stages (pT) and lymph node stages (pN)(n=250) . For pT stages, a significant association is observed between PNI and tumor stage (p < 0.001). PNI is notably absent in pT0  and pT4  stages, while its presence increases with advancing tumor stages from pT1 to pT3.Similarly, for pN stages, a significant association is also observed between PNI and lymph node stage (p < 0.001). PNI is predominantly present in cases categorized as pN0, with no occurrences noted in other lymph node stages. These findings suggest an acute association between PNI and both tumor stage and lymph node involvement in colorectal carcinoma, highlighting the potential significance of PNI in disease progression and prognosis.

Discussion

This retrospective study at Bangabandhu Sheikh Mujib Medical University (BSMMU) investigated the lymphovascular (LVI) and perineural invasion (PNI) in colorectal carcinoma in 250 cases and their association with tumor stages. The average patient age was 47.89 years, with the highest incidence (46.4%) occurring in the 41-60 age group. These findings suggest a higher prevalence in middle and older adults, almost similar to a study in Indonesia with a mean age of 53.2 years [18]. However, our study observed a higher proportion of cases under 50 years old (compared to 38.1% in the Indonesian study). This difference might be due to variations in lifestyle, diet, or environmental factors between the populations. Males were more likely to be diagnosed with CRC (57.20%) compared to females. This could be associated with smoking, alcohol consumption, or a more westernized lifestyle among males. These findings are consistent with a study in Iran [19] that reported 50.9% male patients. The most frequent tumor locations were the ascending colon (29.6%) and sigmoid colon (25.6%). This distribution differs from a study conducted in Bangladesh[20]which found the rectum to be the most common site (36.7%), followed by the sigmoid colon (33.3%). These variations highlight the need for further research on geographical disparities in CRC presentation. Adenocarcinoma NOS (81.2%) was the predominant histological type, followed by mucinous adenocarcinoma (18%). These findings partially align with a study in Poland [21] where adenocarcinoma NOS constituted 87% of cases. Low-grade tumors (82.8%) were more prevalent than high-grade tumors (17.2%). Similarly, stage pT3 (61.2%) was the most common tumor stage, followed by pN0 (56%) for lymph node involvement. These findings differ somewhat from previous studies [22, 23] which reported higher proportions of high-grade tumors and advanced stages. Further investigation is needed to understand these variations. In our stud, we found a strong association between lymphovascular invasion (LVI) and both tumor and lymph node stages in colorectal carcinoma (p=<0.001), which indicates its potential value as a significant prognostic indicator in the disease's progression. In our study, we also observed an acute association between perineural invasion (PNI) and both tumor stages and lymph node involvement in colorectal carcinoma (p=<0.001), which also highlights the potential significance of perineural invasion (PNI) in disease progression and prognosis. Another study found PNI is a common feature in various malignancies and is associated with tumor invasion, metastasis, cancer-related pain, and unfavorable clinical outcomes [24].

Conclusion

In conclusion, this study provides valuable insights into the clinicopathological characteristics of CRC in Bangladeshi patients. Lymphovascular invasion (LVI) and perineural invasion (PNI) were significantly associated with tumor stages of colorectal carcinoma which indicates LVI and PNI are the significant prognostic indicators of CRC disease progression and prognosis.

Limitations of the Study:

This study was conducted in a single center with a limited consecutive sampling technique. Therefore, the results of this study may not reflect the representative scenario of the whole country. Hence a multi-center study may be conducted across the country with an adequate sample size.

Recommendations

Comprehensive policies should be adopted to promote awareness about the growth of colorectal cancer especially among the adult population in Bangladesh to promote colorectal health care at an early stage, screening program, affordable treatment and better prognosis.

Funding:

Self-funding

Conflict of Interest:

None declared

References

  1. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, CA Cancer J Clin 72 (2022): 7-33.
  2. Guyot F, Faivre J, Manfredi S, Meny B, Bonithon-Kopp C, Bouvier A. Time trends in the treatment and survival of recurrences from colorectal cancer. Ann Oncol 16 (2005): 756-61.
  3. Edge, Stephen B, Carolyn C. Compton. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17 (2010): 1471-74.
  4. McLeod HL, Murray GI. Tumour markers of prognosis in colorectal cancer. Br J Cancer 79 (1999): 191-203.
  5. Benson AB, Venook AP, Al-Hawary MM, Arain MA, Chen YJ, Ciombor KK, et al. Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 19 (2021): 329-59.
  6. Liebig C, Ayala G, Wilks JA, Berger DH, Albo D. Perineural invasion in cancer: a review of the literature. Cancer 115 (2009): 3379–91.
  7. Benson AB, Schrag D, Somerfield MR, Cohen AM, Figueredo AT, Flynn PJ, et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol 22 (2004): 3408–19.
  8. Weiss JM, Schumacher J, Allen GO, Neuman H, Lange EO, Loconte NK, et al. Adjuvant chemotherapy for stage II right-sided and left-sided colon cancer: analysis of SEER-medicare data. Ann Surg Oncol 21 (2014): 1781-91.
  9. Booth CM, Nanji S, Wei X, Peng Y, Biagi JJ, Hanna TP, et al. Adjuvant Chemotherapy for Stage II Colon Cancer: Practice Patterns and Effectiveness in the General Population. Clin Oncol (R Coll Radiol) 29 (2017): e29-e38.
  10. Compton CC, Fielding LP, Burgart LJ, Conley B, Cooper HS, Hamilton SR, et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124 (2000): 979-94.
  11. Liebig C, Ayala G, Wilks J, Verstovsek G, Liu H, Agarwal N, et al. Perineural invasion is an independent predictor of outcome in colorectal cancer. J Clin Oncol 27 (2009): 5131
  12. Harris EI, Lewin DN, Wang HL, Lauwers GY, Srivastava A, Shyr Y, et al. Lymphovascular invasion in colorectal cancer: an interobserver variability study. Am J Surg Pathol 32 (2008): 1816–21.
  13. Yuan H, Dong Q, Zheng B, Hu X, Xu JB, Tu S. Lymphovascular invasion is a high-risk factor for stage I/II colorectal cancer: a systematic review and meta-analysis. Oncotarget 8 (2017): 46565–79.
  14. Lim SB, Yu CS, Jang SJ, Kim TW, Kim JH, Kim JC. Prognostic significance of lymphovascular invasion in sporadic colorectal cancer. Dis Colon Rectum 53 (2010): 377–84
  15. Ahadi M, Sokolova A, Brown I, Chou A, Gill AJ. The 2019 World Health Organization Classification of appendiceal, colorectal and anal canal tumours: an update and critical assessment. Pathology 53 (2021): 454-61.
  16. American Society of Clinical Oncology. Colorectal Cancer (2017).
  17. American Joint Committee on Cancer. Chapter 20 - Colon and Rectum. In: AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer (2017).
  18. Rahadiani N, Habiburrahman M, Abdullah M, et al. Analysing 11 years of incidence trends, clinicopathological characteristics, and forecasts of colorectal cancer in young and old patients: a retrospective cross-sectional study in an Indonesian national referral hospital BMJ Open 12 (2022): e060839.
  19. F Hajmanoochehri et al. Clinicopathological Features of Colon Adenocarcinoma in Qazvin, Iran: A 16 Year Study. Asian Pacific Journal of Cancer Prevention 15 (2014): 951-955.
  20. Mahamud MM, Wahed F, Ferdous J, Khan MK. Clinicopathological Assessment of Colorectal Carcinoma in Mymensingh Medical College Hospital, Bangladesh. Mymensingh Med J 26 (2017): 892-899.
  21. Kolos M, Wasaznik-Jedras A & Nasierowska-Guttmejer A. Original paperCan the histological type of colorectal cancer determine the carcinogenesis pathway? Polish Journal of Pathology 66 (2015): 109-120.
  22. Connell WR, Talbot IC, Harpaz N, et al. Clinicopathological characteristics of colorectal carcinoma complicating ulcerative colitis. Gut 35 (1994): 1419-1423.
  23. Anssari S, Elhaitmy Y, Amaadour L, Oualla K, Benbrahim Z, Arifi S et al. Comparison of Clinicopathological and Survival Features of Right and Left Colon Cancers: Experience of the Medical Oncology Department of Fez. Journal of Cancer Therapy 14 (2023): 291-298.
  24. Wang H, Huo R, He K, Cheng L, Zhang S, Yu M, et al. Perineural invasion in colorectal cancer: mechanisms of action and clinical relevance. Cellular Oncology 47 (2024): 1-7.

© 2016-2024, Copyrights Fortune Journals. All Rights Reserved